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ABSTRACT  Asthma is an allergic disease characterized by chronic airway inflammation, 
hyper-responsiveness (AHR), and reversible obstruction. The main inflammatory changes 
are induced by infiltration of eosinophils into the airway. Few animal models resemble the 
spontaneous history of asthma due to variations in the selection of the mouse strain, appropriate 
antigen, and exposure methods. Here, we prepared two different mouse models in which the 
mechanism was close to that of human asthma.
   We transnasally administered mite Dermatophagoides farinae (Df)  allergen to BALB/c mice 
10 times (Df-2) or 25 times (Df-5). After comparison with mice administered phosphate-buffered 
saline, the AHR and immediate asthmatic response were evaluated, in addition to the number 
of eosinophils in the bronchoalveolar lavage fluid (BALF). Df-specific IgE and IgG1 levels in 
the serum, and Th2 cytokines (interleukin [IL]-5, IL-13) in the BALF were measured by enzyme-
linked immunosorbent assay. Immediate asthmatic response and AHR were enhanced in mite 
allergen-treated mice (Df-2 and Df-5) compared to PBS-treated mice. The number of eosinophils 
and IL-13 levels in the BALF, and specific IgE in the serum were greater in Df-5 than in Df-2 
mice. We established two different murine chronic asthma models, in which the severity 
depended on the number of exposures to Df . Greater intranasal exposure to a Df allergen 
resulted in more severe asthma in a BALB/c mouse model. 
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〈Regular Article〉
INTRODUCTION
   Asthma is a chronic inflammatory disease 
characterized by airway hyper-responsiveness 
(AHR) and an increase in airway mucus-secreting 
cells related to airway remodeling. The main 
pathogenesis is chronic airway inflammation 
caused by the infiltration of eosinophils１）. Diverse 
animal models of asthma have been established to 
research the pathologic mechanisms and potential 
therapies２）. Ovalbumin is traditionally used to 
create a sensitized animal model. Ovalbumin is not 
a proper antigen for human asthma pathogenesis, 
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however,  and the intraperi toneal  route for 
sensitization is not appropriately representative of 
the spontaneous history of human asthma onset. 
If exposure to an exogenous antigen elicits airway 
inflammation with eosinophils and AHR, many 
features of the condition may be in common with 
those of human asthma３）. The preparation of a basic 
model in mice with a BALB/c background may be 
useful for elucidating the pathogenesis of allergic 
asthma and drug effectiveness. The severity of the 
airway inflammation almost certainly depends on 
the process of airway allergen exposure, repeated 
allergen administration, dose, and dosing interval 
(i.e., long period and short interval). Study results 
must therefore be carefully interpreted４）.
   In the present study, we prepared two mouse 
models of human asthma by repeated transnasal 
exposure (either 2 or 5 times per week for 5 weeks) 
with the usual allergen in human asthma, the mite 
Dermatophagoides farinae (Df), in BALB/c mice.
MATERIALS AND METHODS
Animal Model
   BALB/c mice (female, 7 weeks old) were obtained 
from Charles River Laboratory (Yokohama, Japan). 
The mite Df allergen (LSL Co., Tokyo, Japan) was 
dissolved with distilled water and adjusted to 1 
mg/ml with phosphate-buffered saline (PBS). The 
mice were sensitized by transnasal administration 
of Df allergen, as described in Fig. 1. The allergen 
(40μl of 1 mg/ml Df) was administered via the 
nasal cavity two or five times a week for 5 weeks 
(sensitization group; Df-2, Df-5, respectively). PBS 
was similarly administered at the same volume 
(40μl) and schedule (twice per week for 5 weeks, 
control group; PBS). All experiments in this study 
were performed according to the protocol approved 
by the Institutional Animal Care and Use Committee 
of Kawasaki Medical School (Protocol Numbers: 
13-006/15-010).
Mouse strain : BALB/c 7-week ٢
Mite Extract – Df (1mg/mL) transnasally 40ȝlق5 weeksك- twice or 5 times in a week
5 times a week for 5 weeks
Day
**AHR
***BAL
*IAR : Immediate Asthmatic Response
**AHR : Airway Hyperresponsiveness
***BAL : Brochoalveolar Lavage
Twice a week for 5 weeks
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*IAR
(Last antigen)
**AHR
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1 2               8 9               15 16           22 23            29 30            36        37
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Fig. 1  Development and evaluation of mite allergen-induced murine model of chronic asthma. BALB/c mice underwent airway 
sensitization two or five times per week for five weeks by intranasal administration of mite-allergen or PBS as described in the 
Materials and Methods. IAR was evaluated for 5 min after the final allergen challenge. AHR was evaluated 24 h after the final 
allergen challenge. BAL was performed after examination of AHR as described in the Materials and Methods. IAR: Immediate 
asthmatic response, AHR: Airway hyper-responsiveness, BAL: Bronchoalveolar lavage. 
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Airway hyper-responsiveness 
   To investigate AHR, mice were forced to inhale 
PBS or acetyl-β-methylcholine chloride (Mch; 
Sigma-Aldrich, St. Louis, MO) at concentrations 
of 3 or 6 mg/ml. The airway resistance (sRaw) in 
awake mice was measured with a two-chambered, 
double-flow plethysmograph system (Pulmos; 
M.I.P.S, Osaka, Japan), as described previously５）. 
Force inhalation was administered for 3 min. After 
a 1-min rest, airway resistance was measured for 2 
min. 
Immediate asthmatic response (IAR) 
   The airway resistance was measured after 
transnasal Df administration to evaluate the rate 
of increase (ΔsRaw) in comparison with the PBS 
exposure airway resistance. sRaw was monitored for 
5 min after Df challenge.
Collection of blood, bronchoalveolar lavage fluid, 
and lung tissue
   After confirming respiratory arrest, blood 
and bronchoalveolar lavage fluid (BALF) were 
collected. Lung tissue specimens were removed for 
hematoxylin and eosin (HE) staining, and Periodic 
acid-Schiff (PAS) staining for pathologic evaluation. 
BALF was obtained by washing the lungs four 
times with 1 mL PBS and centrifuging the collected 
wash solution. The supernatant of the first wash 
was stored at -80℃ until use. Cell pellets of all 
washes were collected and re-suspended in 1 ml 
PBS. The number of BALF cells was counted using 
a cell counter. Cytospin slides were stained with 
Diff-Quik (Sysmex, Kobe, Japan). Differential cell 
counts were performed on at least 400 cells. 
Enzyme-linked immunosorbent assay
   Amounts of interleukin (IL-5) and IL-13 (R&D 
Systems, Minneapolis, MN) in the BALF were 
measured using an enzyme-linked immunosorbent 
assay. The detection limits were 15.6 for IL-5 
and 7.8 pg/mL for IL-13. Df-specific serum 
IgE and IgG1 were measured by enzyme-linked 
immunosorbent assay as previously described６）, 
using biotin-conjugated antibodies against IgE 
(Serotec, Raleigh, NC), IgG1 (Bethyl, Montgomery, 
TX), and streptavidin-horse radish peroxidase 
(Invitrogen, Carlsbad, CA).
Statistical analysis
   All data are expressed as mean ± standard 
deviation (SD) . Statistical analysis was performed 
using GraphPad Prism version 6.0 for Windows 
(GraphPad Software, San Diego, CA). The results 
were compared among the three groups using the 
Kruskal-Wallis test. A P value of less than 0.05 was 
considered significant.
RESULTS
   We first evaluated the IAR after exposure to a 
specific allergen. The airway resistance change 
from PBS (%) at 5 min after exposure (IAR) was 
significantly higher in the Df administration groups 
(Df-2, Df-5) than in the PBS group (p<0.01; Fig. 
2).  We evaluated AHR 24 h after intranasal Df 
challenge using double-flow plethysmography. Df 
challenge induced a significant increase in airway 
hyperresponsiveness to 6 mg/ml Mch in the Df 
administration groups (Df-2, Df-5) compared with 
the PBS control group (p<0.01; Fig. 2).  
   The total number of leukocytes in the BALF 
of the Df administration groups (Df-2, Df-5) 
was significantly higher than that in the PBS 
administration group (1.96 ± 0.86, 2.70 ± 1.11, 
0.75 ± 0.22 x 106/μl, respectively, p<0.01). 
The number of eosinophils in the BALF was 
significantly higher in the Df-5 group than in the 
Df-2 group (p<0.0001; Fig. 3). The BALF of the 
PBS group contained no eosinophils. The numbers 
of neutrophils (p<0.01) and lymphocytes (p<0.01) 
in the Df groups were significantly higher than that 
in the PBS group (Fig. 3).
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Fig. 2  Evaluation of physiologic function.
A. Immidiate Asthmatic Response (IAR) . IAR was evaluated as described in Materials and Methods. PBS: PBS-sensitized group, 
Df-2: Df-sensitized twice a week for 5 weeks group, Df-5: Df-sensitized five times a week for 5 weeks group. Results are shown 
as airway resistance change from baseline. Data represent means ± SD. * p< 0.01 compared with the PBS group
B. Airway-Hyper Responsiveness (AHR). AHR was evaluated as described in the Materials and Methods. Each group was 
exposed to PBS and methacoline-adjusted concentrations (3 and 6 mg/ml) before measuring airway resistance. Data represent 
means ± SD. * p< 0.05 compared with the PBS group
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Fig. 3  Evaluation of inflammatory cell numbers in the BALF
Eosinophils (A), lymphocytes (B), macrophages (C), and neutrophils (D). Data represent means ± SD. * p< 0.01 compared with 
the PBS group. ** p<0.05 compared with Df-2 group. PBS:PBS-sensitized group, Df-2: Df-sensitized twice a week for 5 weeks 
group, Df-5: Df-sensitized 5 times a week for 5 weeks group. 
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   The serum levels of Df-specific IgE and IgG1 
were significantly increased in the Df administration 
groups (Df-2, Df-5) compared with the PBS 
administration group (IgE, p<0 .0001 ,  IgG1 , 
p<0.01; Fig. 4A,B). The serum levels of Df-specific 
IgE were significantly higher in the Df-5 group 
compared with the Df-2 group (p<0.01). The IL-5 
and IL-13 levels in the Df groups were significantly 
higher than in the PBS group (p<0.05). IL-13 levels 
in the Df-5 group were significantly higher than 
in the Df-2 group. We compared the lung tissue 
specimens after HE staining and PAS staining. 
In the Df-5 group, the infiltration of eosinophils 
around the bronchus, mucus-secreting cells, blood 
vessels, and airway wall thickness were more severe 
than in the Df-2 group. There was no infiltration of 
inflammatory cells in the PBS group (Fig. 5). 
DISCUSSION
   In previous studies involving the preparation of a 
mouse model of asthma, the sensitization and intra-
airway allergen administration methods varied, 
and the grade of inflammation depended on the 
frequency of allergen administration, dose, interval, 
and interval from the final dosing until analysis. 
Therefore, the results of those studies must be 
interpreted carefully. As described by Walsh et al., 
the requirements to acquire AHR depend on the 
mouse strain３）. Therefore, a mouse model reflecting 
the development of asthma in humans is necessary 
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Fig. 4  Antigen-specific IgE and IgG1 in serum, and IL-5 and IL-13 in BALF
Df-specific IgE (A), and Df-specific IgG1 (B) in serum, and IL-5 (C) and IL13 (D) in BALF. Data represent means ± SD. * p< 0.05 
compared with the PBS group. ** p<0.05 compared with the Df-2 group. PBS: PBS-sensitized group, Df-2: Df-sensitized twice a 
week for 5 weeks group, Df-5: Df sensitized 5 times a week for 5 weeks group. 
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Fig. 5  Pathologic lung tissue 
Histologic examination of formalin-fixed lung sections stained with hematoxylin and eosin (HE) (A) (original magnification:
× 10), and stained with periodic acid-Schiff (PAS) (B) (original magnification:×40)
(HE x10)-Df-2 (PAS x10)-Df-2
(HE x10)-Df-5 (PAS x10)-Derf/5
(HE x40)-Df-2 (PAS x40)-Df-2
(HE x10)-PBS (HE x40)-PBS(PAS x10)-PBS (PAS x40)-PBS
(PAS x40)-Df-5(HE x40)-Df-5
A B
to clarify the pathogenesis of asthma and establish 
remedies. In the present study, we developed two 
mouse models of asthma with different severities 
after repeated transnasal Df administration (Df-2 
and Df-5). The Df met the following conditions: 
IAR on a specific antigen exposure (ΔsRaw), AHR 
on Mch inhalation, increases in the serum levels of 
Df-specific IgE and IgG1, and an increase in the 
number of eosinophils in the BALF, confirming 
that the characteristics of asthma in humans could 
be reproduced. This mouse model may reflect the 
pathogenesis of human asthma, because the type 
of allergen, mouse strain, and route of sensitization 
differ from those in conventional models such as an 
ovalbumin-sensitized model and that using BALB/c 
mice. 
   Eosinophils are main inflammatory cells with 
many pathophysiologic functions, inducing airway 
contraction, mucus secretion, and enhancement of 
vascular permeability５）. Mast cells were not found 
at the sites of lung inflammation and in the BALF. 
Mast cells may not play an important role in the 
development of AHR and airway inflammation in 
this model. Df-specific IgE levels were higher in the 
Df-5 group than in the Df-2 group. IL-13 levels in 
the BALF of the Df-5 group were also higher than 
that in the Df-2 group. IL-13 might influence the 
production of Df-specific IgE.
   One of the pathophysiologic features of asthma 
is airway remodeling. Airway remodeling consists 
of increased airway wall thickness due to fibrosis 
and increased mucus-secreting cells evaluated by 
PAS staining. In the present study, Df-5 group had 
more sever pathologic feature in the airway than 
Df-2 group. IL-13 might play an important role 
for airway remodeling in mucus secretion. Airway 
remodeling is associated with asthma severity and 
treatment resistance. 
   In conclusion, these two models may reproduce 
not only the characteristics of human asthma, 
such as eosinophilic inflammation of the airway, 
increased AHR, and specific allergen exposure-
7Ikeda M, et al. : Two mite-allergen induced murine chronic asthma models
related obstruction of the airway, but also the 
chemotaxis of eosinophils to local areas and 
airway remodeling. In this study, we successfully 
established two mouse bronchial asthma models 
with different severity reflecting the mode of onset 
in humans in comparison with conventional models, 
using Df allergen and BALB/c mice. Analyses 
of these models may be useful for clarifying the 
pathogenesis of human asthma and the development 
of effective drugs.
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